Patents Examined by Mary C. Lee
  • Patent number: 5391732
    Abstract: A novel process for the preparation of a compound of the formula ##STR1##
    Type: Grant
    Filed: January 4, 1994
    Date of Patent: February 21, 1995
    Assignee: Roussel-Uclaf
    Inventors: Neerja Bhatnagar, Jean Buendia, Christine Griffoul
  • Patent number: 5391798
    Abstract: Process for preparing 6-chloro-(6H)-dibenz[c,e][1,2]oxaphosphorin of the formula (I), ##STR1## in which R.sup.1 and R.sup.2 are identical or different and are halogen, alkyl or alkoxy, each having from 1 to 6 carbon atoms, and a and b are integers from 0 to 3, preferably from 0 to 2, by reaction of o-phenylphenol of the formula (II), ##STR2## in which R.sup.1, R.sup.2, a and b are as defined above, with phosphorus trichloride in the presence of Lewis acids as catalysts with elimination of hydrogen chloride, wherein the phosphorus trichloride is metered into the mixture of compound (II) and Lewis acid at temperatures of 170.degree.-220.degree. C.
    Type: Grant
    Filed: August 9, 1993
    Date of Patent: February 21, 1995
    Assignee: Hoechst Aktiengesellschaft
    Inventor: Hans-Jerg Kleiner
  • Patent number: 5391567
    Abstract: Malignancy-induced hypercalcemia is treated with thionapthene-2-carboxylic acid (TNCA) and the pharmaceutically acceptable salts thereof. The treatment is also effective in tumor bearing hosts even before there is significant abnormal serum calcium levels. There is no "escape" from the hypocalcemic effects of these compounds as with e.g., calcitonin. The useful dosage in humans for TNCA itself ranges from about 1 to about 60 mg/kg/day preferably from about 2 to about 30 mg/kg/day and more preferably from about 5 to about 20 mg/kg/day (20 mg is approximately 0.106 mmol) Orally administered TNCA or salts thereof, is a much desired and obviously clinically advantageous mode of administering compounds to control or ameliorate hypercalcemia.
    Type: Grant
    Filed: September 17, 1993
    Date of Patent: February 21, 1995
    Assignee: Macrochem Corporation
    Inventors: Lawrence G. Raisz, Carlos M. Samour
  • Patent number: 5391764
    Abstract: Polyaspartic acid is produced by hydrolysis of anhydropolyaspartic acid that has been produced by thermal condensation polymerization of L-aspartic acid. Conversion in excess of 80 percent is achievable utilizing "temperature vs. time" profiles.
    Type: Grant
    Filed: March 29, 1994
    Date of Patent: February 21, 1995
    Assignee: Donlar Corporation
    Inventors: Larry P. Koskan, Kim C. Low, Abdul Rehman Y. Meah, Anne Marie Atencio
  • Patent number: 5391757
    Abstract: There are provided novel benzenesulfonyl carboxamide compounds and novel intermediate benzenesulfonyl-2-imidazolin-5-one compounds, novel intermediates and methods for the preparation of said compounds, and a method for controlling a variety of annual and perennial plant species utilizing novel benzenesulfonyl carboxamide compounds and novel intermediate benzenesulfonyl 2-imidazolin-5-one compounds.
    Type: Grant
    Filed: May 9, 1994
    Date of Patent: February 21, 1995
    Assignee: American Cyanamid Company
    Inventors: Sergio I. Alvarado, Alvin D. Crews, Jr., Peter J. Wepplo, Robert F. Doehner, Jr., Thomas E. Brady, David M. Gange, Desiree L. Little
  • Patent number: 5391800
    Abstract: A method of inhibiting tumor cell chemotactic and/or chemoinvasion motility comprising contacting the tumor cell with an inhibitory amount of an agent selected from the group consisting of sphingosine-1-phosphate, derivatives of sphingosine-1-phosphate and mimetics of the sphingosine-1-phosphate or of the derivatives. A method of inhibiting phagokinetic activity of tumor cells and neutrophils comprising contacting the cells with a phagokinetic inhibitory amount of an agent selected from the group consisting of sphingosine-1-phosphate, derivatives of sphingosine-1-phosphate, and mimetics of the sphingosine-1-phosphate or of the derivatives. A method of inhibiting tumor cell metastasis comprising administering to a host in need of treatment a metastasis inhibitory amount of an agent selected from the group consisting of sphingosine-1-phosphate, derivatives of sphingosine-1-phosphate, and mimetics of the sphingosine-1-phosphate or of the derivatives, and pharmaceutically acceptable salts of the agent.
    Type: Grant
    Filed: August 9, 1993
    Date of Patent: February 21, 1995
    Assignee: The Biomembrane Institute
    Inventors: Yasuyuki Igarashi, Fuqiang Ruan, Yoshito Sadahira, Shigeyuki Kawa, Sen-itiroh Hakomori
  • Patent number: 5391717
    Abstract: Reactive dyes of the formula ##STR1## in which D, R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are as defined in claim 1, are particularly suitable for dyeing or printing cellulosic fiber materials or naturally occurring or synthetic polyamide fiber materials with a high tinctorial yield, and produce dyeings and prints having good fastness properties.
    Type: Grant
    Filed: July 19, 1993
    Date of Patent: February 21, 1995
    Assignee: Ciba-Geigy Corporation
    Inventors: Athanassios Tzikas, Rolf Deitz
  • Patent number: 5391718
    Abstract: Reactive dyes of the formula ##STR1## in which K and Z are as defined in the disclosure, are suitable in particular for the dyeing and printing of cellulose-containing fibre material and produce dyeings and prints having good fastness properties in high coloristic yield.
    Type: Grant
    Filed: February 26, 1993
    Date of Patent: February 21, 1995
    Assignee: Ciba-Geigy Corporation
    Inventors: Athanassios Tzikas, Claudia Carisch
  • Patent number: 5391716
    Abstract: Monoazo reactive dyestuffs of the formula ##STR1## wherein the substituents have the meaning given in the description, are particularly suitable for dyeing materials containing OH groups or amide groups.
    Type: Grant
    Filed: May 4, 1993
    Date of Patent: February 21, 1995
    Assignee: Bayer Aktiengesellschaft
    Inventors: Konrad Bootz, Hermann Henk
  • Patent number: 5389619
    Abstract: Compounds of the formula I ##STR1## where n, W, X, Y, Z, R.sup.1, R.sup.2, and R.sup.3 are as defined herein exhibit fungicidal, insecticidal, and acaracidal activity.
    Type: Grant
    Filed: March 29, 1993
    Date of Patent: February 14, 1995
    Assignee: BASF Aktiengesellschaft
    Inventors: Reinhard Doetzer, Hubert Sauter, Horst Wingert, Reinhard Kirstgen, Albrecht Harreus, Gisela Lorenz, Eberhard Ammermann
  • Patent number: 5389663
    Abstract: An azole compound represented by the formula (I): ##STR1## wherein X is a nitrogen atom; Ar is a phenyl group substituted by halogen or a halogenated C.sub.1-4 alkyl group; R.sup.1 and R.sup.2 independently are a hydrogen atom or a lower alkyl group, or R.sup.1 and R.sup.2 may combine together to form a lower alkylene group; n denotes an integer of 0 to 2; and R.sup.7 is a hydrogen atom, a hydroxyl group which may be optionally acylated by an acyl group selected from acetyl, propionyl, butyryl, isobutyryl, phenylacetyl and benzoyl, or may form a bond together with R.sup.1 ; or a salt thereof.
    Type: Grant
    Filed: November 24, 1993
    Date of Patent: February 14, 1995
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Katsumi Itoh, Kenji Okonogi, Akihiro Tasaka
  • Patent number: 5389661
    Abstract: This invention relates to novel substituted imidazole and triazole derivatives which antagonize the binding of angiotensin II to its receptors. The compounds are useful in the treatment of hypertension, heart failure, glaucoma, and hyperaldosteronism. Methods of making the compounds, novel intermediates useful in the preparation of the compounds, pharmaceutical compositions containing the compounds, and methods of using them are also covered.
    Type: Grant
    Filed: February 10, 1994
    Date of Patent: February 14, 1995
    Assignee: Warner-Lambert Company
    Inventors: Ila Sircar, Jagadish C. Sircar
  • Patent number: 5387674
    Abstract: There are described formazan dyes of the formula ##STR1## where n is 1 or 2,Kat.sup..sym. is the equivalent of a cation,Me is copper or nickel,X is a radical of the formula CO--O or SO.sub.2 --O,Y is vinyl or a radical of the formula C.sub.2 H.sub.4 --Q, where Q is a group which is detachable under alkaline reaction conditions,the ring A may be substituted and benzofused, the ring B is substituted and may be benzofused, and the ring C may be substituted, the use thereof for dyeing or printing hydroxyl- or nitrogen-containing organic substrates, and novel hydrazones.
    Type: Grant
    Filed: September 8, 1993
    Date of Patent: February 7, 1995
    Assignee: BASF Aktiengesellschaft
    Inventors: Claus Marschner, Manfred Patsch
  • Patent number: 5387708
    Abstract: A process for the production of dialkyl carbonates, such as dimethyl carbonate. In one aspect, the process involves contacting under reaction conditions an alkanol, such as methanol, with carbon monoxide and oxygen in the vapor phase and in the presence of a catalyst containing (1) a copper halide, a copper oxyhalide, or a copper carboxylate halide, (2) a quaternary ammonium salt, and (3) a support component. The catalyst achieves high selectivity and productivity to dialkyl carbonates. In a second aspect, the addition of a chlorocarbon catalyst regenerator to the alkanol feed increases catalyst stability and lifetime and increases the selectivity and/or productivity to dialkyl carbonates.
    Type: Grant
    Filed: December 10, 1993
    Date of Patent: February 7, 1995
    Assignee: The Dow Chemical Company
    Inventors: David C. Molzahn, Mark E. Jones, George E. Hartwell, Jose Puga
  • Patent number: 5387603
    Abstract: Indoline compounds represented by the formula: ##STR1## wherein R represents a saturated or unsaturated aliphatic acyl group which may have one or more halogen atoms, a hydroxy group, a lower alkoxy group, a carboxy group, a lower alkoxycarbonyl group, a cycloalkyl group or an aryl group as substituents; a hydroxyalkyl group; an aliphatic acyloxyalkyl group; a lower alkyl group having a lower alkoxy group, a carboxy group, a lower alkoxycarbonyl group, an aryl substituted lower alkoxycarbonyl group, a carbamoyl group, a mono- or dialkyl substituted carbamoyl group or a cyano group as substituents; an aromatic acyl group which may have one or more halogen atoms as substituents; a furoyl group or a pyridylcarbonyl group; R.sup.
    Type: Grant
    Filed: December 1, 1993
    Date of Patent: February 7, 1995
    Assignee: Kissei Pharmaceutical Co., Ltd.
    Inventors: Makio Kitazawa, Masaaki Ban, Kosuke Okazaki, Motoyasu Ozawa, Toshikazu Yazaki, Ryoichi Yamagishi
  • Patent number: 5387374
    Abstract: Guerbet carbonates corresponding to formula (I) ##STR1## in which R.sup.1 is a branched alkyl radical containing 12 to 44 carbon atoms and R.sup.2 has the same meaning as R.sup.1 or is a linear alkyl radical containing 1 to 12 carbon atoms; their use as lubricants; and a process for their preparation in which Guerbet alcohols are used to transesterify dialkyl carbonates of formula III ##STR2## in which R.sup.3 is a linear alkyl radical containing 1 to 12 carbon atoms.
    Type: Grant
    Filed: June 15, 1993
    Date of Patent: February 7, 1995
    Assignee: Henkel Kommanditgesellschaft auf Aktien
    Inventors: Alfred Westfechtel, Frank Bongardt, Achim Ansmann
  • Patent number: 5385927
    Abstract: New 2-hydroxyl-3-[1-(1H-imidazol-4-yl)alkyl]-benzenecarboximidamides as well as their salts, having the formula ##STR1## wherein R.sub.1 is hydrogen or an alkyl radical having 1 to 4 carbon atoms,R.sub.2 is hydrogen a hydroxyl group, an amino group or an alkyl radical having 1 to 4 carbon atoms,R.sub.3 is hydrogen, or R.sub.2 and R.sub.3 together are --CH.sub.2 -CH.sub.2 --;processes for the preparation thereof, and ophthalmic compositions comprising the same are also described. These compounds are capable of lowering intraocular pressure and can be used in the prevention and treatment of glaucoma.
    Type: Grant
    Filed: May 24, 1994
    Date of Patent: January 31, 1995
    Assignee: U C B, S.A.
    Inventors: Philippe Michel, Eric Cossement, Jean Gobert, Ernst Wulfert
  • Patent number: 5385923
    Abstract: 4-R.sup.4 --R.sup.5 -2-Saccharinylmethyl aryl and aryloxy acetates, useful in the treatment of degenerative diseases, are prepared by reacting a 4-R.sup.4 --R.sup.5 -2-halomethylsaccharin with an aryl or aryloxyacetic acid in the presence of an acid-acceptor.
    Type: Grant
    Filed: August 20, 1993
    Date of Patent: January 31, 1995
    Assignee: Sterling Winthrop Inc.
    Inventors: Lee H. Latimer, Richard P. Dunlap
  • Patent number: 5384413
    Abstract: The present invention relates to a process for the preparation of tetrafluorophthalic acid and/or tetrafluorophthalic anhydride by reacting a compound of the formula ##STR1## in which X is a radical ##STR2## which is optionally mono- or polysubstituted on the aromatic nucleus by fluorine and/or chlorine and/or alkyl groups having 1 to 4 carbon atoms, or is a radical ##STR3## in which R.sub.1, R.sub.2 and R.sub.3 are as defined, with water, and subsequently removing the water still present by azeotropic distillation or extracting the tetrafluorophthalic acid and/or its anhydride with a water-insoluble solvent or solvent mixture.
    Type: Grant
    Filed: July 12, 1993
    Date of Patent: January 24, 1995
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Ralf Pfirmann, Theodor Papenfuhs
  • Patent number: 5384325
    Abstract: Compounds based on heterobicyclic derivatives displaying fungicidal activity, having the general formula (I): ##STR1##
    Type: Grant
    Filed: April 25, 1994
    Date of Patent: January 24, 1995
    Assignee: Isagro S.r.l.
    Inventors: Giovanni Camaggi, Lucio Filippini, Marilena Gusmeroli, Raul Riva, Carlo Garavaglia, Ernesto Signorini, Mario Ferri